Gene therapy for tuberous sclerosis
US-2024343768-A1 · Oct 17, 2024 · US
US9511115B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9511115-B2 |
| Application number | US-89739710-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 4, 2010 |
| Priority date | Feb 16, 2005 |
| Publication date | Dec 6, 2016 |
| Grant date | Dec 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein is a pharmaceutical composition for treating, preventing or ameliorating a bone or cartilage condition and methods of making and using the same.
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical composition for treating, preventing, or ameliorating a bone related condition in a mammal, comprising an effective amount of a NELL peptide and a carrier or scaffold that includes BMP2 and hyaluronan, wherein the effective amount is effective for a bone related condition selected from the group consisting of osteoporosis, bone loss due to microgravity, disuse atrophy, prolonged bed-rest, and a disease that involves multiple symptoms w…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.